JP2008500963A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500963A5 JP2008500963A5 JP2007503063A JP2007503063A JP2008500963A5 JP 2008500963 A5 JP2008500963 A5 JP 2008500963A5 JP 2007503063 A JP2007503063 A JP 2007503063A JP 2007503063 A JP2007503063 A JP 2007503063A JP 2008500963 A5 JP2008500963 A5 JP 2008500963A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- antigen
- mixed
- immunomodulatory oligonucleotide
- tcttrctgtct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55287104P | 2004-03-12 | 2004-03-12 | |
| PCT/US2005/008238 WO2005089231A2 (en) | 2004-03-12 | 2005-03-11 | Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008500963A JP2008500963A (ja) | 2008-01-17 |
| JP2008500963A5 true JP2008500963A5 (cg-RX-API-DMAC7.html) | 2008-05-15 |
Family
ID=34994209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007503063A Pending JP2008500963A (ja) | 2004-03-12 | 2005-03-11 | 第二世代免疫調節性オリゴヌクレオチドを用いて増幅されたhivワクチン活性 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050266015A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1729802A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008500963A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101217973A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005222909B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2557443A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005089231A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| AR040996A1 (es) | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
| NZ540098A (en) | 2002-10-29 | 2008-09-26 | Coley Pharmaceutical Group Ltd | Use of CPG oligonucleotides in the treatment of hepatitis C virus infection |
| MY159370A (en) | 2004-10-20 | 2016-12-30 | Coley Pharm Group Inc | Semi-soft-class immunostimulatory oligonucleotides |
| US7470674B2 (en) * | 2005-11-07 | 2008-12-30 | Idera Pharmaceuticals, Inc. | Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| MX2009003398A (es) | 2006-09-27 | 2009-08-12 | Coley Pharm Gmbh | Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada. |
| HRP20181039T1 (hr) * | 2010-05-28 | 2018-08-24 | Zoetis Belgium S.A. | Cjepiva koja sadrže kolesterol i cpg kao jedine molekule koje nose adjuvans |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5912332A (en) * | 1996-07-26 | 1999-06-15 | Hybridon, Inc. | Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides |
| JP4726630B2 (ja) * | 2003-01-16 | 2011-07-20 | イデラ ファーマシューティカルズ インコーポレイテッド | 修飾された免疫賦活性ジヌクレオチドを用いることによるオリゴヌクレオチドに基づく化合物の免疫賦活特性の調節 |
| OA13246A (en) * | 2003-08-28 | 2007-01-31 | Immune Response Corp Inc | Immunogenic HIV Compositions and related methods. |
-
2005
- 2005-03-11 CA CA002557443A patent/CA2557443A1/en not_active Abandoned
- 2005-03-11 AU AU2005222909A patent/AU2005222909B2/en not_active Ceased
- 2005-03-11 JP JP2007503063A patent/JP2008500963A/ja active Pending
- 2005-03-11 WO PCT/US2005/008238 patent/WO2005089231A2/en not_active Ceased
- 2005-03-11 EP EP05725427A patent/EP1729802A4/en not_active Withdrawn
- 2005-03-11 US US11/078,654 patent/US20050266015A1/en not_active Abandoned
- 2005-03-11 CN CNA2005800079845A patent/CN101217973A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007095976A3 (de) | Adjuvanz in form einer lipid-modifizierten nukleinsäure | |
| JP2006316072A5 (cg-RX-API-DMAC7.html) | ||
| WO2009095226A3 (en) | NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS | |
| WO2007062107A3 (en) | Immunostimulatory oligoribonucleotides | |
| EP1766096A4 (en) | SIV AND HIV VACCINATION WITH RHCMV AND HCMV BASED IMPFECTORS | |
| JP2005237328A5 (cg-RX-API-DMAC7.html) | ||
| JP2009539965A5 (cg-RX-API-DMAC7.html) | ||
| JP2003503454A5 (cg-RX-API-DMAC7.html) | ||
| RU2007127993A (ru) | Сахарид-конъюгатные вакцины | |
| CA2321523A1 (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
| JP2003526662A5 (cg-RX-API-DMAC7.html) | ||
| JP2007533729A5 (cg-RX-API-DMAC7.html) | ||
| RU2013119946A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| WO2007057763A3 (en) | Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant | |
| EP2302059A8 (en) | Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization | |
| EA201101432A1 (ru) | Активный фармацевтический ингредиент, адсорбированный на твердой подложке | |
| PT1383752E (pt) | 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos | |
| JP2022521410A5 (cg-RX-API-DMAC7.html) | ||
| JP2009514840A5 (cg-RX-API-DMAC7.html) | ||
| WO2005111079A3 (en) | Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41 | |
| WO2005021726A3 (en) | Immunogenic hiv compositions and related methods | |
| WO2005089231A3 (en) | Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide | |
| JP2009514527A5 (cg-RX-API-DMAC7.html) | ||
| JP2007505923A5 (cg-RX-API-DMAC7.html) | ||
| EP1905449A3 (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |